Nanoparticle Platform with Extensive Patent Coverage.

Minerva Biotechnologies was founded in 1999 by Dr Cynthia Bamdad (inventor of the universal DNA chip & protein chip) to develop next generation biochips: affinity nanoparticles. Minerva enjoys a broad and dominant intellectual property position in the field of nanotechnology with over 100 patent applications filed...

 

Listen to Dr. Bamdad's interview on NW and American Airlines this month.


29
APr
Cancer paper. PLoSone Publishes Minerva  cancer research article.

5
MAY
Major press releases of cancer paper announced to the public.

2
oct
Stem Cell paper. PLoSone Publishes Minerva  stem cell research article.